W. Brooks Gentry

Fondateur chez InterveXion Therapeutics LLC

Health Technology

Consumer Services

Profil

W.
Brooks Gentry is the founder and Chief Medical Officer of InterveXion Therapeutics LLC, which is founded in 2004.
He is currently a Professor at The University of Arkansas, a position he has held since 2000.

Postes actifs de W. Brooks Gentry

Sociétés	Poste	Début
InterveXion Therapeutics LLC InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR.	Fondateur	17/09/2009
The University of Arkansas	Corporate Officer/Principal	17/09/2009

Tous les postes actifs de W. Brooks Gentry

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de W. Brooks Gentry

Relations

100 +

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	1
InterveXion Therapeutics LLC InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR.	Health Technology